Hu et al. demonstrated that estrogen can activate tafazzin (TAZ) through GPR30 to regulate the Hippo pathway and promote breast cancer cell proliferation and migration as well as tumor growth (86). This evidence concerns the gene GPER1 and breast carcinoma.